Concepedia

Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial <scp>SORAMIC</scp>

Jens Ricke, K Bulla, Frank T. Kolligs, Markus Peck‐Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki,

Liver International · 2014 · 80 citations · 19 references

DOI

Abstract

Radioembolization followed by sorafenib appears to be as well tolerated as sorafenib alone.

References

19

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 12.8K citations · Full text

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

, , +12

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Journal of Hepatology · 2012 · 5.2K citations

, , +5

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

Riad Salem, Robert J. Lewandowski, Mary F. Mulcahy et al. · Gastroenterology · 2009 · 1.1K citations

, , +11

Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

Bruno Sangro, L Carpanese, Roberto Cianni et al. · Hepatology · 2011 · 648 citations · Full text